These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33835765)

  • 1. Structural and physiological changes of the human body upon SARS-CoV-2 infection.
    Wu Z; Zhang Q; Ye G; Zhang H; Heng BC; Fei Y; Zhao B; Zhou J
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):310-317. PubMed ID: 33835765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhang T; Sun LX; Feng RE
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.
    Konopka KE; Nguyen T; Jentzen JM; Rayes O; Schmidt CJ; Wilson AM; Farver CF; Myers JL
    Histopathology; 2020 Oct; 77(4):570-578. PubMed ID: 32542743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.
    El Jamal SM; Pujadas E; Ramos I; Bryce C; Grimes ZM; Amanat F; Tsankova NM; Mussa Z; Olson S; Salem F; Miorin L; Aydillo T; Schotsaert M; Albrecht RA; Liu WC; Marjanovic N; Francoeur N; Sebra R; Sealfon SC; García-Sastre A; Fowkes M; Cordon-Cardo C; Westra WH
    Hum Pathol; 2021 Aug; 114():110-119. PubMed ID: 33961839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
    Deinhardt-Emmer S; Wittschieber D; Sanft J; Kleemann S; Elschner S; Haupt KF; Vau V; Häring C; Rödel J; Henke A; Ehrhardt C; Bauer M; Philipp M; Gaßler N; Nietzsche S; Löffler B; Mall G
    Elife; 2021 Mar; 10():. PubMed ID: 33781385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Changes and Cause of Death Associated with the Global Novel Coronavirus Disease (COVID-19).
    Yang B; Xu LY; Li LY; Qiao DF; DU SH; Yue X; Wang HJ
    Fa Yi Xue Za Zhi; 2023 Dec; 39(6):586-595. PubMed ID: 38228478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of SARS-CoV-2 pneumonia.
    Sagnelli C; Celia B; Monari C; Cirillo S; De Angelis G; Bianco A; Coppola N
    J Med Virol; 2021 Mar; 93(3):1276-1287. PubMed ID: 32856728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmortem Findings Associated With SARS-CoV-2: Systematic Review and Meta-analysis.
    Satturwar S; Fowkes M; Farver C; Wilson AM; Eccher A; Girolami I; Pujadas E; Bryce C; Salem F; El Jamal SM; Paniz-Mondolfi A; Petersen B; Gordon RE; Reidy J; Fraggetta F; Marshall DA; Pantanowitz L
    Am J Surg Pathol; 2021 May; 45(5):587-603. PubMed ID: 33481385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Post-mortem SARS-CoV-2 RT-PCR of Autopsies with COVID-19-Suggestive Pathology Supports the Absence of Lethal Community Spread in Basel, Switzerland, before February 2020.
    Haslbauer JD; Perrina V; Matter M; Dellas A; Mihatsch MJ; Tzankov A
    Pathobiology; 2021; 88(1):95-105. PubMed ID: 33161409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).
    Beeraka NM; Tulimilli SV; Karnik M; Sadhu SP; Pragada RR; Aliev G; Madhunapantula SV
    Biomed Res Int; 2021; 2021():8160860. PubMed ID: 34159203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
    Guo J; Wei X; Li Q; Li L; Yang Z; Shi Y; Qin Y; Zhang X; Wang X; Zhi X; Meng D
    J Cell Physiol; 2020 Dec; 235(12):9884-9894. PubMed ID: 32510598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
    Shao C; Liu H; Meng L; Sun L; Wang Y; Yue Z; Kong H; Li H; Weng H; Lv F; Jin R
    Hum Pathol; 2020 Jul; 101():82-88. PubMed ID: 32437706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
    Wong NA; Saier MH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.